Regulation & Compliance

U.S. Anesthesia Partners will settle a major antitrust lawsuit, signaling a victory for federal regulators and new rules for healthcare consolidation.

The healthcare tech firm rebrands its flagship products, signaling a deeper push into AI to combat rising claim denials and coding errors.

The automaker partners with Liquid AI to bring fast, private, and cloud-independent intelligence to its cars, challenging the industry's reliance on big tech.

With a $4.6M seed round, Cloneable's new agentic AI platform captures the invaluable knowledge of retiring infrastructure experts to prevent a looming brain drain.

ENA Respiratory appoints GSK veteran Melissa Faris to its board, a strategic move signaling an accelerated push for its innovative virus-agnostic nasal spray.

By manufacturing its own drug test cups, 12PanelNow bypasses distributors, promising lower costs and greater reliability for critical testing needs.

An upcoming webinar offers a rare look into Ukraine's surrogacy industry, where parental dreams clash with the harsh realities and ethical quandaries of war.

Canopy's new AI Notetaker integrates directly into its platform, promising to end fragmented workflows and provide deep, accounting-specific client insights.

Apricorn's new 32TB drive, the market's largest hardware-encrypted desktop unit, offers a massive offline fortress for enterprise data security.

Global law firm Freshfields is deploying Anthropic's Claude AI to 5,700 staff, a landmark move signaling a new era of tech-driven competition for legal giants.

Football legend Luis Figo is the new face of TenTrade, but the deal highlights growing scrutiny over celebrity endorsements of high-risk finance.

New partnership combines Spotline's regulatory automation with SAS Viya to help pharma and biotech move to the cloud faster and with less compliance risk.

A new chip from Skymizer claims to run massive 700B AI models on a single card, challenging the need for costly GPU clusters for on-premise AI.

The packaging giant posts 11% EBITDA growth, navigating commodity spikes while announcing a German plant closure and a key leadership change in its glass arm.

As Québec mulls a ban on energy drink sales to minors, the beverage industry clashes with health advocates over science, risk, and regulation.

Millions of Britons lose a night's sleep weekly, with the sickest suffering most. As traditional remedies fail, many are now exploring medical cannabis.

With 15,000 clinicians already on board, an AI platform officially launches in South Africa, aiming to combat burnout and a looming healthcare crisis.

Acebet's new zero-fee PvP slot modes attract thousands, but its controversial offshore license and gray-market US strategy raise significant questions.

A novel drug, NP137, shows unprecedented results in a Phase 1 trial, potentially making inoperable pancreatic tumors treatable and improving survival.

Breakthrough trial data shows a new device can keep donor hearts viable for longer, potentially expanding the organ pool and saving thousands on waitlists.